CELLARES
Live / Registered — Registered (as of 23 Mar 2021)
What this means for you
Registered since 23 Mar 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88980220
- Registration number
- 6302820
- Mark type
- Stylized text
- Filed
- 24 May 2019
- Published for opposition
- 31 Mar 2020
- Registered
- 23 Mar 2021
- Attorney of record
- Bobby A. Ghajar
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of cell therapies; Scientific research in human and animal cell therapy; Technical assessments relating to design, namely, technical design consultation in the field of manufacture of advanced therapy and cell therapy medications; Technical research in the field of manufacture of advanced therapy and cell therapy medications
Owner
- Cellares Corporation, San Francisco, CA, US
- Cellares Corporation, San Francisco, CA, US
- Cellares Corporation, San Francisco, CA, US
Prosecution history
- 23 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Jul 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Jul 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Sept 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Sept 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Sept 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Feb 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Feb 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Feb 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
- 13 Feb 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Feb 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Jan 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Dec 2020 — USE AMENDMENT FILED